Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03586895 · ClinicalTrials.gov registry record · NA

e-Connect: A Service System Intervention for Justice Youth at Risk for Suicide

A NA study of Suicide, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
12,838
Enrollment target
1
Study location

NCT03586895: Recruiting NA study of Suicide, sponsored by Columbia University.

NCT03586895 is a NA study of Suicide that is actively recruiting participants, run by Columbia University. The registered enrollment target is 12,838 participants, above the 6,850-participant average among 92 other Suicide trials with a reported enrollment target (87% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03586895, a NA study of Suicide, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
12,838 participants
Enrollment target
1
Study location

Study Summary

The investigators propose to create e-Connect, a new service delivery model that will enable real time identification and targeted, county-specific referral and linkage of participants with suicidal behavior (SB) and related behavioral health (BH) problems. e-Connect will: (i) establish and formalize interagency referral decisions based on clinical need, jointly derived by JJ (juvenile justice) and BH agencies; (ii) train probation staff to increase BH/SB understanding; (iii) utilize an existing evidence-based (EB) BH/SB screen; and (iv) develop a mobile application to seamlessly integrate screening, classification of clinical need and development of a related referral plan. There are 4 project phases: Development, Baseline, Implementation, and Sustainment/Evaluation. After development, activities take place in 10 NY (New York) counties and all study counties will begin the intervention at the same time. The investigators will examine changes in outcomes (e.g., service use) relative to baseline in (i) identification of participants service need (SB and BH correlates) in juvenile probationers; (ii) cross-system (probation-BH agency) referral; and (iii) participants BH service use (access and engagement). Analyses will further consider contributions of multi-level factors (e.g., staff, organizational, family, and community) that influence implementation (feasibility, acceptability, sustainability) of e-Connect across various probation department processing categories (e.g. status offenders, diversion cases). The investigators will consider the role of mediating elements (e.g., probation practices) in explaining the association between e-Connect and identification, referral, and service use.

Primary Outcome

Date of first behavioral health appointment/contact extracted from state management information system (MIS)

Conditions Studied

Interventions

  • BEHAVIORAL e-Connect

Study Locations (1)

New York

  • Columbia University - New York

Trial Details

FieldValue
Enrollment Target 12,838 participants
Start Date 2019-08-01
Est. Completion 2025-12-01
Phase NA
Columbia University

958 total trials

What NCT03586895 shows while recruiting

NCT03586895 is an interventional study that assigns participants to a tested intervention. Its 12,838 participants enrollment target places it among the larger protocols in the corpus, above the 6,850-participant average among 92 other Suicide trials with a reported enrollment target (87% higher).

The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which e-Connect is the first listed.

NCT03586895 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03586895 about?

NCT03586895 is a clinical study titled "e-Connect: A Service System Intervention for Justice Youth at Risk for Suicide". The investigators propose to create e-Connect, a new service delivery model that will enable real time identification and targeted, county-specific referral and linkage of participants with suicidal behavior (SB) and related behavioral health (BH) problems. e-Connect will: (i) establish and formaliz...

What is the current status of trial NCT03586895?

This trial is currently recruiting. It is a NA study. The enrollment target is 12,838 participants. The study started on 2019-08-01. Estimated completion is 2025-12-01.

What conditions does trial NCT03586895 study?

This clinical trial studies the following conditions: Suicide.

What interventions are being tested in trial NCT03586895?

The interventions under investigation include: e-Connect (BEHAVIORAL).

Who is sponsoring clinical trial NCT03586895?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03586895 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03586895's enrollment target sits among peer trials

12,838 4th of 92 higher than 89 of 92 other Suicide trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07037433 · 12,800 participants · Phase 3

    Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • NCT07028398 · 12,990 participants · NA

    CMSL Ambulatory Sensitive Condition Nudge Study 2

  • NCT05991453 · 13,000 participants · NA

    Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

  • NCT07177352 · 13,000 participants · Phase 3

    Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03586895, the US trial registry maintained by the National Library of Medicine. NCT03586895 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.